Insider · CIK 0001606243
James Paul Rickey
Files at ALPN (ALPINE IMMUNE SCIENCES, INC.), BRVE (Braveheart Bio, Inc.). First filing Nov 8, 2023, latest Aug 7, 2026.
In brief
James Paul Rickey files SEC Form 4 as CFO at ALPN (ALPINE IMMUNE SCIENCES, INC.), and also at BRVE (Braveheart Bio, Inc.). Since Nov 8, 2023, James Paul Rickey has reported 1 open-market buy worth $500k and 6 open-market sells worth $5.6M, the latest filed on Aug 7, 2026.
A track record needs three past buys with six months of prices behind them; James Paul Rickey has 0, so none is measured yet.
The newest scored trade: bought $500k of BRVE on Aug 7, 2026, filed Aug 7, 2026, scored 58 (moderate). In the last 12 months: 1 buy worth $500k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BRVE: Braveheart Bio, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 58Moderate | Braveheart Bio, Inc. | $500k 27,777 shares | +6% | - | |
| 25Weak | ALPINE IMMUNE SCIENCES, INC. | $2.8M 118,000 shares | -50000% | - | |
| 29Weak | ALPINE IMMUNE SCIENCES, INC. | $292k 15,213 shares | -100% | - | |
| 40Moderate | ALPINE IMMUNE SCIENCES, INC. | $1.1M 58,787 shares | -507% | - | |
| 33Weak | ALPINE IMMUNE SCIENCES, INC. | $1.1M 70,811 shares | -111% | - | |
| 8Weak | ALPINE IMMUNE SCIENCES, INC. | $11k 700 shares | -100% | - | |
| 14Weak | ALPINE IMMUNE SCIENCES, INC. | $289k 18,003 shares | -100% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jan 26, 2024 | ALPN ALPINE IMMUNE SCIENCES INC | 44,000 0.08% of outstanding | $957k | Jan 26, 2024 | $2.9M |
| Jan 25, 2024 | ALPN ALPINE IMMUNE SCIENCES INC | 74,000 0.13% of outstanding | $1.4M | Jan 25, 2024 | $2.9M |
| Dec 15, 2023 | ALPINE IMMUNE SCIENCES INC | 62,400 0.11% of outstanding | $1.2M | Dec 15, 2023 | $1.7M |
| Dec 14, 2023 | ALPINE IMMUNE SCIENCES INC | 11,600 0.02% of outstanding | $218k | Dec 14, 2023 | $1.4M |
| Nov 6, 2023 | ALPINE IMMUNE SCIENCES INC | 89,514 0.18% of outstanding | $1.4M | Nov 6, 2023 | none |
Transactions
The newest 50 of 62 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | POpen-market purchase Common Stock | +27,777 | $18.00 | $500k | 520,927 | Aug 7, 2026 |
| Aug 5, 2026 | BRVE Braveheart Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +300,000 | $0.00 | $0 | 300,000 | Aug 7, 2026 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Common Stock | -26,761 | - | - | 31,200 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Common Stock | -31,200 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -836 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -137 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -143 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -1,214 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -112,945 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -112,500 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -108,999 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -78,000 | - | - | 0 | May 20, 2024 |
| May 7, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock | +1 | $7.55 | $8 | 31,201 | May 9, 2024 |
| May 7, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock | +7,055 | $13.20 | $93k | 38,256 | May 9, 2024 |
| May 7, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock | +857 | $6.51 | $5,579 | 39,113 | May 9, 2024 |
| May 7, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock | +164 | $11.31 | $1,855 | 39,277 | May 9, 2024 |
| May 7, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock | +18,286 | $3.23 | $59k | 57,563 | May 9, 2024 |
| May 7, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock | +398 | $5.02 | $1,998 | 57,961 | May 9, 2024 |
| May 7, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative | -1 | $0.00 | $0 | 108,999 | May 9, 2024 |
| May 7, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative | -7,055 | $0.00 | $0 | 112,945 | May 9, 2024 |
| May 7, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative | -857 | $0.00 | $0 | 143 | May 9, 2024 |
| May 7, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative | -164 | $0.00 | $0 | 836 | May 9, 2024 |
| May 7, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative | -18,286 | $0.00 | $0 | 1,214 | May 9, 2024 |
| May 7, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative | -398 | $0.00 | $0 | 137 | May 9, 2024 |
| Jan 25, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +236 | $6.51 | $1,536 | 236 | Jan 29, 2024 |
| Jan 25, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -236 | $22.00 | $5,192 | 0 | Jan 29, 2024 |
| Jan 26, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +73,764 | $6.51 | $480k | 73,764 | Jan 29, 2024 |
| Jan 26, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -73,764 | $22.31 | $1.6M | 0 | Jan 29, 2024 |
| Jan 26, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +44,000 | $11.31 | $498k | 44,000 | Jan 29, 2024 |
| Jan 26, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -44,000 | $25.00 | $1.1M | 0 | Jan 29, 2024 |
| Jan 25, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative10b5-1 | -236 | $0.00 | $0 | 74,764 | Jan 29, 2024 |
| Jan 26, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative10b5-1 | -73,764 | $0.00 | $0 | 1,000 | Jan 29, 2024 |
| Jan 26, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative10b5-1 | -44,000 | $0.00 | $0 | 1,000 | Jan 29, 2024 |
| Jan 4, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | AGrant or award Common Stock | +31,200 | $0.00 | $0 | 31,200 | Jan 5, 2024 |
| Jan 4, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | AGrant or award Stock Option (Right to buy)derivative | +78,000 | $0.00 | $0 | 78,000 | Jan 5, 2024 |
| Dec 19, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +15,213 | $5.02 | $76k | 15,213 | Dec 21, 2023 |
| Dec 19, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -15,213 | $19.21 | $292k | 0 | Dec 21, 2023 |
| Dec 19, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative10b5-1 | -15,213 | $0.00 | $0 | 535 | Dec 21, 2023 |
| Dec 14, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +11,600 | $5.02 | $58k | 11,600 | Dec 18, 2023 |
| Dec 14, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -11,600 | $19.00 | $220k | 0 | Dec 18, 2023 |
| Dec 15, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +45,387 | $5.02 | $228k | 45,387 | Dec 18, 2023 |
| Dec 15, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -45,387 | $19.09 | $866k | 0 | Dec 18, 2023 |
| Dec 18, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +1,800 | $5.02 | $9,036 | 1,800 | Dec 18, 2023 |
| Dec 18, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -1,800 | $19.00 | $34k | 0 | Dec 18, 2023 |
| Dec 14, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative10b5-1 | -11,600 | $0.00 | $0 | 62,935 | Dec 18, 2023 |
| Dec 15, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative10b5-1 | -45,387 | $0.00 | $0 | 17,548 | Dec 18, 2023 |
| Dec 18, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative10b5-1 | -1,800 | $0.00 | $0 | 15,748 | Dec 18, 2023 |
| Dec 4, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +63,947 | $3.23 | $207k | 63,947 | Dec 6, 2023 |
| Dec 4, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -63,947 | $16.06 | $1.0M | 0 | Dec 6, 2023 |
| Dec 5, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +418 | $3.23 | $1,350 | 418 | Dec 6, 2023 |
Questions about James Paul Rickey
Answered from the filings on this page, as of the latest one.
Is James Paul Rickey buying or selling?
In the last 12 months James Paul Rickey reported 1 open-market buy worth $500k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $500k of BRVE on Aug 7, 2026. Grants, option exercises and tax withholding are not counted.
How did James Paul Rickey's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and James Paul Rickey has 0.
Where does James Paul Rickey file Form 4?
James Paul Rickey has filed Form 4 at ALPN (ALPINE IMMUNE SCIENCES, INC.) as See Remarks; BRVE (Braveheart Bio, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.